Flavel Heyman
Corneal and Contact Management · Gibson City, ILNPI 1144281411
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.3%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. Alcon accounts for 70.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $1,145 and has fallen 87.8% since, to $139 in 2025.
Across 15 payments — averaging $118.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Regeneron Healthcare Solutions, Inc.$125
- Harrow Eye, LLC$120
- Bausch & Lomb Americas Inc.$116
- Glaukos Corporation$93
- Johnson & Johnson Vision Care, Inc.$45
- plus $19 from 1 others
What the payments were for
- Travel & lodging$81446%
- Food & beverage$94953%
- Entertainment$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 8 | $1,263 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Harrow Eye, LLC | 1 | $120 |
| Bausch & Lomb Americas Inc. | 1 | $116 |
| Glaukos Corporation | 2 | $93 |
| Johnson & Johnson Vision Care, Inc. | 1 | $45 |
| Optos, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES$903
- AIR OPTIX$689
- EYLEA$125
- AcrySof IQ VIVITY IOL$124
- VEVYE$120
- INFUSE MULTIFOCAL$116
How this compares
$1,782 in reported general payments places this provider in the 65th percentile of 34 corneal and contact management providers in Illinois.
See all corneal and contact management providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 17 | $10,760 |
| Cyclosporine | 35 | $9,342 |
| LumiganBimatoprost | 18 | $7,681 |
| Latanoprost | 304 | $4,179 |
| Travoprost | 14 | $1,698 |
| Prednisolone Acetate | 25 | $1,089 |
| Timolol Maleate | 88 | $606 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 18 | $184 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 13 | $183 |
Paid to pharmacies, not to this prescriber.
Other corneal and contact management in Gibson City
- Jennifer WongChicago$37K
- Tiffany AndrzejewskiHighland Park$29K
- Haris DzuburOak Lawn$26K
- Robert SteinmetzChicago$10K
- Cesar LauChicago$3K
- Ryan NguyenChicago$3K
- Matthew McGeeChicago$3K
- Alan KarikomiChicago$3K
- Dawn WickizerAlgonquin$3K
- Paul VeltingMorton$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.